Aging
Devyani Misra, MD, MSc
Beth Israel Deaconess Medical Center, Boston
Boston, MA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Cornelia M. Weyand, MD, PhD
Mayo Clinic School of Medicine and Stanford University
Rochester, MN, United States
Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing); Gilead: Advisor or Review Panel Member (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing)
Aging is a physiologic process with multi-system decline. Of relevance to rheumatologists, the immune system undergoes changes with aging that leads to rheumatic diseases that disproportionately develop at late-age counterparts. Also, the age or difference in their characteristics from their younger-related changes in the immune system can impact response to treatments, with varying outcomes. The goal of this symposium is to provide learners information on age-related changes in the immune system of practical relevance to clinical rheumatology with introduction to the concept of premature aging, how late onset rheumatic diseases differ in their characteristics from early-onset (focusing on rheumatoid arthritis) and real-world challenges in treating older adults with rheumatic diseases with efficacy and toxicity of disease modifying anti-proposal rationale rheumatic drugs (DMARDs).
Speaker: Cornelia M. Weyand, MD, PhD – Mayo Clinic School of Medicine and Stanford University
Speaker: Devyani Misra, MD, MSc – Beth Israel Deaconess Medical Center, Boston
